IBM Vice President to Present Keynote at Livingston Nanotechnology Conference

Axiom Capital Management and Scott Livingston today announced that the third annual Axiom Capital Management "Livingston Nanotechnology Conference" will feature a keynote presentation by Dr. Bernard Meyerson, IBM Vice President for Strategic Alliances and CTO, IBM Systems and Technology Group. Dr. Meyerson will discuss innovation in large organizations, and how radical innovation, integrated with radical collaboration, enables mature companies to keep ahead of upstarts.

"We are thrilled to have Dr. Meyerson talk to our group at our annual gathering." said Scott Livingston, Managing Director of Axiom Capital Management and head of the Livingston Group, a division of Axiom Capital Management Inc. focused exclusively on nanotechnology, "Dr. Meyerson is one of a handful of individuals whose contributions to the advancement of semiconductor manufacturing in America has truly been indispensable. We are proud that our annual event brings together leaders like Dr. Meyerson to help our institutional investor and corporate attendees understand the opportunities presented by advances at the nanoscale."

The third annual Axiom Capital Management "Livingston Nanotechnology Conference" is being held on December 7 at the Marriott Financial Center in Downtown New York City. The conference will bring together blue chip corporations, promising startups and leading investors to discuss investment and business trends in nanotechnology. For more information and registration information please visit http://www.axiomcapital.com/nanotech_2007/index.htm.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.